Gillian Payne
Vice President, Analytical Development | Newton, Massachusetts, United States
Professional Overview
Gillian Payne is an accomplished pharmaceutical executive with over 25 years of experience in analytical development, bioanalytical sciences, and product development. As the Vice President of Analytical Development at Carbon Biosciences, she is responsible for leading a team of scientists and overseeing the analytical strategies and methods validation for the company's innovative biotherapeutic pipeline.
Experience Summary
Current Role
As the Vice President of Analytical Development at Carbon Biosciences, Gillian is responsible for developing and implementing robust analytical strategies to support the company's preclinical and clinical programs. She leads a team of highly skilled scientists in the design, optimization, and validation of analytical methods to ensure the quality, safety, and efficacy of Carbon Biosciences' novel biotherapeutics. Gillian's expertise in navigating regulatory requirements and her ability to drive cross-functional collaboration have been instrumental in advancing the company's pipeline and strengthening its position as a leader in the biotechnology industry.
Career Progression
Prior to joining Carbon Biosciences, Gillian held various leadership roles in analytical development and bioanalytical sciences at prominent biotechnology companies. As the Executive Director of Analytical Development at CRISPR Therapeutics, she was responsible for establishing the analytical strategies and quality control systems to support the development of their gene-editing therapies. Before that, she served as the Director of Analytical Development at bluebird bio, where she played a pivotal role in the analytical characterization and release of their gene therapy products.
Gillian's career at ImmunoGen Inc. spanned over two decades, where she progressed from a research and development role in biochemistry and discovery research to becoming the Executive Director of the Analytical Development and AML Product Teams. Her extensive experience in the design and implementation of bioanalytical methods, as well as her leadership in cross-functional product teams, have positioned her as a respected expert in the field of biotherapeutic development.
Academic Background
Gillian holds a Bachelor of Science degree in Biochemistry from the University of Massachusetts, Amherst. Her strong academic foundation, coupled with her extensive industry experience, has enabled her to develop a comprehensive understanding of the analytical challenges and regulatory requirements in the biotechnology sector.
Areas of Expertise
- Analytical method development and validation
- Bioanalytical sciences and assay optimization
- Quality control and process development
- Cross-functional collaboration and project management
- Regulatory compliance and industry best practices
- Leadership and team management
Professional Impact
Gillian's contributions to the field of analytical development have been recognized by her peers. She has presented her work at numerous industry conferences and has been actively involved in various professional organizations, where she shares her expertise and insights with the broader biopharmaceutical community. Gillian's commitment to advancing the field of analytical development, coupled with her strategic vision and collaborative approach, have been instrumental in driving the success of the companies she has worked for.
Conclusion
Gillian Payne is a seasoned pharmaceutical executive with a proven track record of leading analytical development teams and driving the successful advancement of biotherapeutic pipelines. Her deep expertise, coupled with her strong leadership skills and ability to navigate complex regulatory environments, make her a valuable asset to any organization in the biotechnology industry.
